5 reports

  • Novogen to Enter into Co-Development Agreement with Feinstein Institute for Medical Research for Brain Cancer
  • Novogen Forms Joint Venture With Yale University

Summary Kazia Therapeutics Ltd (Kazia) is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs.It develops its products based on three drug technology platforms, phosphoinositide 3-kinase (PI3K) inhibitors, anti-tropomyosins (ATM) and super-benzopyrans (SBP). ATM...

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Novogen Limited
  • Novogen to Enter into Co-Development Agreement with Feinstein Institute for Medical Research for Brain Cancer
  • Novogen Forms Joint Venture With Yale University

Summary Novogen Ltd (Novogen) is a clinical stage biotechnology company which focuses on the discovery and development of anti-cancer drugs. It develops its products based on three drug technology platforms, phosphoinositide 3-kinase (PI3K) inhibitors, anti-tropomyosins (ATM) and super-benzopyrans (SBP). ATM drugs...

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Therapy
  • Novogen Limited
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H1 2018
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.
  • Toll Like Receptor 8 (CD288 or TLR8) - Therapeutics Development
  • Toll Like Receptor 8 (CD288 or TLR8) - Dormant Products

In this trial, ## patients with PASI scores of ##. ## or greater will be randomized ##:##:##:## to receive weekly subcutaneous doses of IMO-## at ##. ##, ##. ##, or ##. ## mg/ kg/ week or placebo for ## weeks.

  • Cancer
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Idera Pharmaceuticals, Inc.
  • against all brain cancer cell lines tested.
  • Key Information

Novogen Limited - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Novogen Limited - Product Pipeline Review - 2015’, provides an overview of the Novogen Limited’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental...

  • Cancer
  • Research And Development
  • World
  • Company Operations
  • Novogen Limited